High frequency of central nervous system involvement in transformed Waldenstrom € macroglobulinemia

Eric Durot; Lukshe Kanagaratnam; Saurabh Zanwar; Elise Toussaint; Efstathios Kastritis; Shirley D’Sa; Miguel Alcoceba; Cecile Tomowiak; Benedicte Hivert; Caroline Protin; Jithma P. Abeykoon; Josephine M. I. Vos; Anne-Sophie Michallet; Cyrielle Rodier; Jehan Dupuis; Stephane Leprêtre; Fatiha Merabet; Xavier Roussel; Jean-Marc Zini; Caroline Regny; Aisha Patel; Pierre Morel; Damien Roos-Weil; Steven P. Treon; Meletios A. Dimopoulos; Ramon Garcia-Sanz; Prashant Kapoor; Jorge J. Castillo; Alain Jacques Delmer

doi:https://doi.org/10.1182/bloodadvances.2022007331

High frequency of central nervous system involvement in transformed Waldenstrom € macroglobulinemia

Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, Elise Toussaint, Efstathios Kastritis, Shirley D’Sa, Miguel Alcoceba, Cecile Tomowiak, Benedicte Hivert, Caroline Protin, Jithma P. Abeykoon, Josephine M. I. Vos, Anne-Sophie Michallet, Cyrielle Rodier, Jehan Dupuis, Stephane Leprêtre, Fatiha Merabet, Xavier Roussel, Jean-Marc Zini, Caroline RegnyAisha Patel, Pierre Morel, Damien Roos-Weil, Steven P. Treon, Meletios A. Dimopoulos, Ramon Garcia-Sanz, Prashant Kapoor, Jorge J. Castillo, Alain Jacques Delmer

Research output: Contribution to journal › Comment/Letter to the editor › Academic

4 Citations (Scopus)

Original language	English
Pages (from-to)	3655-3658
Number of pages	4
Journal	Blood advances
Volume	6
Issue number	12
DOIs	https://doi.org/10.1182/bloodadvances.2022007331
Publication status	Published - 28 Jun 2022

Access to Document

https://doi.org/10.1182/bloodadvances.2022007331

Cite this

Durot, E., Kanagaratnam, L., Zanwar, S., Toussaint, E., Kastritis, E., D’Sa, S., Alcoceba, M., Tomowiak, C., Hivert, B., Protin, C., Abeykoon, J. P., Vos, J. M. I., Michallet, A.-S., Rodier, C., Dupuis, J., Leprêtre, S., Merabet, F., Roussel, X., Zini, J.-M., ... Delmer, A. J. (2022). High frequency of central nervous system involvement in transformed Waldenstrom € macroglobulinemia. Blood advances, 6(12), 3655-3658. https://doi.org/10.1182/bloodadvances.2022007331

@article{b17ca7d3a73543cfad5f13c077093b36,

title = "High frequency of central nervous system involvement in transformed Waldenstrom € macroglobulinemia",

author = "Eric Durot and Lukshe Kanagaratnam and Saurabh Zanwar and Elise Toussaint and Efstathios Kastritis and Shirley D{\textquoteright}Sa and Miguel Alcoceba and Cecile Tomowiak and Benedicte Hivert and Caroline Protin and Abeykoon, {Jithma P.} and Vos, {Josephine M. I.} and Anne-Sophie Michallet and Cyrielle Rodier and Jehan Dupuis and Stephane Lepr{\^e}tre and Fatiha Merabet and Xavier Roussel and Jean-Marc Zini and Caroline Regny and Aisha Patel and Pierre Morel and Damien Roos-Weil and Treon, {Steven P.} and Dimopoulos, {Meletios A.} and Ramon Garcia-Sanz and Prashant Kapoor and Castillo, {Jorge J.} and Delmer, {Alain Jacques}",

note = "Funding Information: Acknowledgments: This work was supported by Cancer Research UK [C355/A26819], FC AECC, and AIRC under the “Accelerator Award Program” [EDITOR] to M.A. and R.G.-S. Funding Information: and consulting fees from Beigene and Janssen. P.K. is a principal investigator of studies for which Mayo Clinic has received research funding from AbbVie, Sanofi, Amgen, GSK, Ichnos, Takeda, Regen-eron, and Karyopharm; has received honoraria from X4 Pharmaceuticals, Beigene, Pharmacyclics, Imidex, Clinical Care Options, GSK, Oncopeptides, Cellectar, and Karyopharm. J.J.C. received research funds and consulting fees from Abbvie, AstraZeneca, Beigene, Jans-sen, Pharmacyclics, Polyneuron, Roche, and TG Therapeutics. The remaining authors declare no competing financial interests.",

year = "2022",

month = jun,

day = "28",

doi = "https://doi.org/10.1182/bloodadvances.2022007331",

language = "English",

volume = "6",

pages = "3655--3658",

journal = "Blood advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "12",

}

Durot, E, Kanagaratnam, L, Zanwar, S, Toussaint, E, Kastritis, E, D’Sa, S, Alcoceba, M, Tomowiak, C, Hivert, B, Protin, C, Abeykoon, JP, Vos, JMI, Michallet, A-S, Rodier, C, Dupuis, J, Leprêtre, S, Merabet, F, Roussel, X, Zini, J-M, Regny, C, Patel, A, Morel, P, Roos-Weil, D, Treon, SP, Dimopoulos, MA, Garcia-Sanz, R, Kapoor, P, Castillo, JJ & Delmer, AJ 2022, 'High frequency of central nervous system involvement in transformed Waldenstrom € macroglobulinemia', Blood advances, vol. 6, no. 12, pp. 3655-3658. https://doi.org/10.1182/bloodadvances.2022007331

TY - JOUR

T1 - High frequency of central nervous system involvement in transformed Waldenstrom € macroglobulinemia

AU - Durot, Eric

AU - Kanagaratnam, Lukshe

AU - Zanwar, Saurabh

AU - Toussaint, Elise

AU - Kastritis, Efstathios

AU - D’Sa, Shirley

AU - Alcoceba, Miguel

AU - Tomowiak, Cecile

AU - Hivert, Benedicte

AU - Protin, Caroline

AU - Abeykoon, Jithma P.

AU - Vos, Josephine M. I.

AU - Michallet, Anne-Sophie

AU - Rodier, Cyrielle

AU - Dupuis, Jehan

AU - Leprêtre, Stephane

AU - Merabet, Fatiha

AU - Roussel, Xavier

AU - Zini, Jean-Marc

AU - Regny, Caroline

AU - Patel, Aisha

AU - Morel, Pierre

AU - Roos-Weil, Damien

AU - Treon, Steven P.

AU - Dimopoulos, Meletios A.

AU - Garcia-Sanz, Ramon

AU - Kapoor, Prashant

AU - Castillo, Jorge J.

AU - Delmer, Alain Jacques

N1 - Funding Information: Acknowledgments: This work was supported by Cancer Research UK [C355/A26819], FC AECC, and AIRC under the “Accelerator Award Program” [EDITOR] to M.A. and R.G.-S. Funding Information: and consulting fees from Beigene and Janssen. P.K. is a principal investigator of studies for which Mayo Clinic has received research funding from AbbVie, Sanofi, Amgen, GSK, Ichnos, Takeda, Regen-eron, and Karyopharm; has received honoraria from X4 Pharmaceuticals, Beigene, Pharmacyclics, Imidex, Clinical Care Options, GSK, Oncopeptides, Cellectar, and Karyopharm. J.J.C. received research funds and consulting fees from Abbvie, AstraZeneca, Beigene, Jans-sen, Pharmacyclics, Polyneuron, Roche, and TG Therapeutics. The remaining authors declare no competing financial interests.

PY - 2022/6/28

Y1 - 2022/6/28

UR - http://www.scopus.com/inward/record.url?scp=85132841903&partnerID=8YFLogxK

U2 - https://doi.org/10.1182/bloodadvances.2022007331

DO - https://doi.org/10.1182/bloodadvances.2022007331

M3 - Comment/Letter to the editor

C2 - 35290439

SN - 2473-9529

VL - 6

SP - 3655

EP - 3658

JO - Blood advances

JF - Blood advances

IS - 12

ER -

High frequency of central nervous system involvement in transformed Waldenstrom € macroglobulinemia

Access to Document

Other files and links

Cite this